| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requester: Good Fit; Isoflucypram fits well within southeastern IPM programs. Its SDHI mode of action provides an effective rotation companion where Monilinia fructicola resistance to DMIs has been documented, improving resistance management options. Application timing aligns with bloom and preharvest disease monitoring, and the product is compatible with cultural practices such as sanitation and canopy management. Isoclucypram's systemic activity, long residual, and low risk to beneficials make it a strong candidate for reducing reliance on older chemistries and enhancing brown rot control under high disease pressure:07/26;
|
| Reasons for need: |
Monilinia. Resistance to DMI fungicides. Current technologies used: Propiconazole, sanitation:07/26;
|
| Requesting State(s): |
AL:Vinson, E* ;
|
| PCR Use Pattern: |
Foliar application; IR4 suggest 20.5 fl. oz/A product
|
| EPA Default Residue Trials: |
1 2-4 4 5 6 10-4
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|